Literature DB >> 23780631

[Obesity in the elderly: clinical relevance and therapy options].

M Lechleitner1.   

Abstract

The prevalence of obesity is increasing, also in the elderly population. During advancing age in adulthood body weight continues to increase up to peak values at about 65 years of age followed by a decline in older age. Overweight and obesity are related to an increase in the cardiometabolic risk, but also to an increased incidence of degenerative joint disease, functional limitations, and immobility. An increase in mortality risk was demonstrated for BMI values > 30 kg/m(2), which are in the range of obesity. It is therefore suggested to consider weight reduction in obese elderly primarily with respect to weight-related comorbidities and functional limitations that may benefit from weight loss. The central aim of weight loss in the obese elderly is to improve quality of life. Nutritional recommendations combined with individually adapted exercise programs are helpful to prevent malnutrition, sarcopenia, and osteoporosis. No data are available about the safety of drug therapy for weight reduction in the elderly.

Entities:  

Mesh:

Year:  2013        PMID: 23780631     DOI: 10.1007/s00391-013-0511-y

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  37 in total

1.  Sarcopenic obesity: the confluence of two epidemics.

Authors:  Ronenn Roubenoff
Journal:  Obes Res       Date:  2004-06

2.  Physiopathological mechanism of sarcopenia.

Authors:  Stéphane Walrand; Christelle Guillet; Jérome Salles; Noël Cano; Yves Boirie
Journal:  Clin Geriatr Med       Date:  2011-08       Impact factor: 3.076

3.  Longitudinal change in height of men and women: implications for interpretation of the body mass index: the Baltimore Longitudinal Study of Aging.

Authors:  J D Sorkin; D C Muller; R Andres
Journal:  Am J Epidemiol       Date:  1999-11-01       Impact factor: 4.897

4.  Relationship between body mass index and mortality among Europeans.

Authors:  X Song; J Pitkäniemi; W Gao; R J Heine; K Pyörälä; S Söderberg; C D A Stehouwer; B Zethelius; J Tuomilehto; T Laatikainen; A G Tabák; Q Qiao
Journal:  Eur J Clin Nutr       Date:  2011-08-10       Impact factor: 4.016

5.  Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy.

Authors:  Wilfred Druml; Barbara Metnitz; Eva Schaden; Peter Bauer; Philipp G H Metnitz
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

Review 6.  Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study.

Authors:  J L Gutiérrez-Fisac; P Guallar-Castillón; L M León-Muñoz; A Graciani; J R Banegas; F Rodríguez-Artalejo
Journal:  Obes Rev       Date:  2011-12-12       Impact factor: 9.213

Review 7.  Obesity and weight management in the elderly.

Authors:  T S Han; Abdelouahid Tajar; M E J Lean
Journal:  Br Med Bull       Date:  2011-02-16       Impact factor: 4.291

Review 8.  Sarcopenic obesity: definition, cause and consequences.

Authors:  Sari Stenholm; Tamara B Harris; Taina Rantanen; Marjolein Visser; Stephen B Kritchevsky; Luigi Ferrucci
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-11       Impact factor: 4.294

Review 9.  Weight loss in obese adults 65years and older: a review of the controversy.

Authors:  Debra L Waters; Aimee L Ward; Dennis T Villareal
Journal:  Exp Gerontol       Date:  2013-02-10       Impact factor: 4.032

Review 10.  Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline.

Authors:  Elisabeth M H Mathus-Vliegen
Journal:  Obes Facts       Date:  2012-06-30       Impact factor: 3.942

View more
  1 in total

1.  Body mass index and waist circumference predict health-related quality of life, but not satisfaction with life, in the elderly.

Authors:  Lucy Wang; John D Crawford; Simone Reppermund; Julian Trollor; Lesley Campbell; Bernhard T Baune; Perminder Sachdev; Henry Brodaty; Katherine Samaras; Evelyn Smith
Journal:  Qual Life Res       Date:  2018-06-07       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.